High-activity mutants of cocaine esterase for treatment of drug addiction
用于治疗药物成瘾的可卡因酯酶高活性突变体
基本信息
- 批准号:8084218
- 负责人:
- 金额:$ 49.98万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-08-15 至 2013-06-30
- 项目状态:已结题
- 来源:
- 关键词:Adverse effectsBehavioralCatalysisCocaineCocaine DependenceComputational TechniqueCoupledDoseDrug AddictionEnzymesEvaluationFree EnergyHealthHybridsHydrolysisIn VitroInvestigationLeadMechanicsMetabolismModelingMolecularMolecular ModelsPerformancePharmaceutical PreparationsPreclinical TestingProcessProtocols documentationReactionRodent ModelRoentgen RaysSite-Directed MutagenesisStructureTestingToxic effectbasecocaine esterasecocaine overdosecocaine usecomputer studiesdesignesteraseimmunogenicityimprovedin vivomodels and simulationmolecular dynamicsmolecular modelingmutantnovelpreclinical studypreventprotein expressionprotein purificationquantumresponsetherapeutic effectivenessthree dimensional structuretreatment strategy
项目摘要
DESCRIPTION (provided by applicant): Enhancing cocaine metabolism by administration of cocaine esterases has been recognized as a promising treatment strategy for cocaine overdose and addiction. The esterase CocE is the most efficient native enzyme for metabolizing naturally occurring (-)-cocaine yet identified. Through catalysis of (-)-cocaine hydrolysis, CocE can both prevent and reverse extreme (-)- cocaine toxicity in rodent models and it has the potential to be developed into a chemically useful antagonist of the toxic and behavioral effects of (-)-cocaine. In order to optimize the efficacy of this potential anti-cocaine medication and minimize its possible side effects (particularly immunogenicity), we propose to improve the catalytic efficiency of CocE against (-)- cocaine. The higher the catalytic efficiency of the enzyme against (-)-cocaine, the lower the dose required to achieve therapeutic effectiveness and the decrease in dose can reduce the overall immunological response. Hence we will focus on the rational design, discovery, and preclinical testing of CocE mutants with an improved catalytic efficiency against (-)-cocaine. The rational design of high-activity mutants of CocE against (-)-cocaine requires a detailed understanding of the mechanism for CocE-catalyzed hydrolysis of cocaine. This mechanism can be understood by performing computational studies using the state-of-the-art computational techniques of molecular modeling, simulation, and calculation. The specific aims include: (1) Elucidation of the detailed mechanism and reaction coordinate and the corresponding free energy profiles for CocE-catalyzed hydrolysis of cocaine by performing quantum mechanical (QM) calculations, hybrid quantum mechanical/molecular mechanical (QM/MM) calculations, and molecular dynamics (MD) simulations, etc. (2) Design, discovery, and testing of CocE mutants with an improved catalytic efficiency against (-)-cocaine by using a recently developed novel computational design approach based on the transition state modeling and simulation to computationally evaluate a large number of hypothetical CocE mutants, followed by wet experimental tests including site-directed mutagenesis, protein expression and purification, and in vitro and in vivo activity tests. The long-term objective of this investigation will be to eventually develop an efficient anti-cocaine medication using a high-activity mutant of CocE. PUBLIC HEALTH RELEVANCE: Enhancing cocaine metabolism by administration of cocaine esterase (CocE) has been recognized as a promising treatment strategy for cocaine overdose and addiction. The high-activity mutants of CocE to be designed and discovered in this project will eventually lead to an efficient anti-cocaine medication.
描述(由申请人提供):通过给药可卡因酯酶增强可卡因代谢已被认为是可卡因过量和成瘾的有前途的治疗策略。酯酶COCE是用于代谢天然发生的最有效的天然酶( - )可卡因尚未鉴定出来。通过( - ) - 可卡因水解的催化,COCE可以预防和反向极端( - ) - 可卡因毒性中的可卡因毒性,并且它有可能发展为( - ) - 可卡因的毒性和行为效应的化学有用的拮抗剂。为了优化这种潜在的抗可卡因药物的功效,并最大程度地减少其可能的副作用(尤其是免疫原性),我们建议提高COCE对( - ) - 可卡因的催化效率。酶对( - )可卡因的催化效率越高,实现治疗效果所需的剂量越低,剂量降低可以降低总体免疫学反应。因此,我们将重点关注COCE突变体的合理设计,发现和临床前测试,其催化效率提高了( - ) - 可卡因。 COCE对( - ) - 可卡因的高活动性突变体的合理设计需要对可卡因的CoCE催化水解的机制有详细的理解。可以通过使用分子建模,仿真和计算的最新计算技术进行计算研究来理解这种机制。具体目的包括:(1)通过执行量子力学(QM)计算,阐明可卡因的详细机制和反应坐标以及相应的自由能谱,用于可卡因的水解,杂种量子机械/分子/分子机械/mm/mm/mm/mm/mm/mm/mm)的杂种量子和分子验证(MOD)和分子动力学(MD)的模拟(MD)的象征(MD)(MD)的设计(MD)(MD)(2)设计,通过使用最近开发的新型计算设计方法基于过渡状态建模和模拟来计算评估大量假设的COCE突变体,然后进行湿的实验测试,包括位置定向的诱变,蛋白质表达和纯化,以及体外和体内活性测试,包括湿的实验测试。这项研究的长期目标将是最终使用COCE的高活动性突变体开发有效的抗可卡因药物。公共卫生相关性:通过给药可卡因酯酶(COCE)增强可卡因代谢,已被认为是可卡因过量和成瘾的有前途的治疗策略。在该项目中设计和发现的COCE的高活动性突变体最终将导致有效的抗可卡因药物。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DONALD W LANDRY其他文献
DONALD W LANDRY的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DONALD W LANDRY', 18)}}的其他基金
Development of amodiaquine and its analogs as reactivators of organophosphate-inh
作为有机磷-inh再激活剂的阿莫地喹及其类似物的开发
- 批准号:
8416866 - 财政年份:2012
- 资助金额:
$ 49.98万 - 项目类别:
Development of amodiaquine and its analogs as reactivators of organophosphate-inh
作为有机磷-inh再激活剂的阿莫地喹及其类似物的开发
- 批准号:
8551780 - 财政年份:2012
- 资助金额:
$ 49.98万 - 项目类别:
Metabolism in Heart Failure Translational Research Center
心力衰竭代谢转化研究中心
- 批准号:
7859108 - 财政年份:2009
- 资助金额:
$ 49.98万 - 项目类别:
Metabolism in Heart Failure Translational Research Center
心力衰竭代谢转化研究中心
- 批准号:
7937864 - 财政年份:2009
- 资助金额:
$ 49.98万 - 项目类别:
High-activity mutants of cocaine esterase for treatment of drug addiction
用于治疗药物成瘾的可卡因酯酶高活性突变体
- 批准号:
7674510 - 财政年份:2008
- 资助金额:
$ 49.98万 - 项目类别:
High-activity mutants of cocaine esterase for treatment of drug addiction
用于治疗药物成瘾的可卡因酯酶高活性突变体
- 批准号:
8286381 - 财政年份:2008
- 资助金额:
$ 49.98万 - 项目类别:
High-activity mutants of cocaine esterase for treatment of drug addiction
用于治疗药物成瘾的可卡因酯酶高活性突变体
- 批准号:
7506455 - 财政年份:2008
- 资助金额:
$ 49.98万 - 项目类别:
High-activity mutants of cocaine esterase for treatment of drug addiction
用于治疗药物成瘾的可卡因酯酶高活性突变体
- 批准号:
7883683 - 财政年份:2008
- 资助金额:
$ 49.98万 - 项目类别:
COCAINE CATALYTIC ANTIBODIES: NOVEL TECHNOLOGY FOR DEMAND REDUCTION
可卡因催化抗体:减少需求的新技术
- 批准号:
6258830 - 财政年份:1997
- 资助金额:
$ 49.98万 - 项目类别:
相似国自然基金
由煤沥青构筑原位弥散原子级别Fe-Al的二维贯穿孔结构碳纳米片及其对多硫化锂的催化转化行为
- 批准号:52372045
- 批准年份:2023
- 资助金额:51 万元
- 项目类别:面上项目
锡(铋、铟)氧/硫化物在CO2电还原过程中的重构行为与催化机制研究
- 批准号:52372217
- 批准年份:2023
- 资助金额:51 万元
- 项目类别:面上项目
单层MWW分子筛结晶组装机理及其催化傅克酰基化反应行为
- 批准号:22378325
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
水介质中芳香硝基类污染物催化还原活性物种的限速行为研究
- 批准号:22306110
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
磁耦合等离激元光催化剂的构筑对光生载流子迁移和光催化制氢行为的影响
- 批准号:22309038
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
High-activity mutants of cocaine esterase for treatment of drug addiction
用于治疗药物成瘾的可卡因酯酶高活性突变体
- 批准号:
7674510 - 财政年份:2008
- 资助金额:
$ 49.98万 - 项目类别:
High-activity mutants of cocaine esterase for treatment of drug addiction
用于治疗药物成瘾的可卡因酯酶高活性突变体
- 批准号:
8286381 - 财政年份:2008
- 资助金额:
$ 49.98万 - 项目类别:
High-activity mutants of cocaine esterase for treatment of drug addiction
用于治疗药物成瘾的可卡因酯酶高活性突变体
- 批准号:
7506455 - 财政年份:2008
- 资助金额:
$ 49.98万 - 项目类别:
High-activity mutants of cocaine esterase for treatment of drug addiction
用于治疗药物成瘾的可卡因酯酶高活性突变体
- 批准号:
7883683 - 财政年份:2008
- 资助金额:
$ 49.98万 - 项目类别:
L-DOPA OVERLOAD: MECHANISMS FOR THE SIDE EFFECTS.
左旋多巴超载:副作用的机制。
- 批准号:
7827511 - 财政年份:2006
- 资助金额:
$ 49.98万 - 项目类别: